Bioreductively Activatable Prodrug Conjugates of Phenstatin Designed to Target Tumor Hypoxia

A variety of solid tumor cancers contain significant regions of hypoxia, which provide unique challenges for targeting by potent anticancer agents. Bioreductively activatable prodrug conjugates (BAPCs) represent a promising strategy for therapeutic intervention. BAPCs are designed to be biologically...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Bioorg Med Chem Lett
Auteurs principaux: Winn, Blake A., Shi, Zhe, Carlson, Graham J., Wang, Yifan, Nguyen, Benson L., Kelly, Evan M., Ross, R. David, Hamel, Ernest, Chaplin, David J., Trawick, Mary L., Pinney, Kevin G.
Format: Artigo
Langue:Inglês
Publié: 2016
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5319644/
https://ncbi.nlm.nih.gov/pubmed/28007448
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bmcl.2016.11.093
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires